Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 | SpringerLink

Share it with your friends Like

Thanks! Share it with your friends!

Close

“Rather than rush to market a questionable vaccine it might be far wiser to give Vit. D supplements to everyone or at least to those in high risk groups so their levels, if low, can be brought up to an effective range. But since that would interfere with the medical establishments profits I doubt that will occur so it is up to each individual to do it themselves. If possible get your D levels tested then you’ll know what if anything you need to do.

Hypovitaminosis, a condition brought about by the lack of an essential vitamin.

Click the link below to read the full details of the study, if desired.” Admin

Purpose

Hypovitaminosis D is a highly spread condition correlated with increased risk of respiratory tract infections. Nowadays, the world is in the grip of the Coronavirus disease 19 (COVID 19) pandemic. In these patients, cytokine storm is associated with disease severity. In consideration of the role of vitamin D in the immune system, aim of this study was to analyse vitamin D levels in patients with acute respiratory failure due to COVID-19 and to assess any correlations with disease severity and prognosis.

 

Methods

 

In this retrospective, observational study, we analysed demographic, clinical and laboratory data of 42 patients with acute respiratory failure due to COVID-19, treated in Respiratory Intermediate Care Unit (RICU) of the Policlinic of Bari from March, 11 to April 30, 2020.

 

Results

 

Eighty one percent of patients had hypovitaminosis D. Based on vitamin D levels, the population was stratified into four groups: no hypovitaminosis D, insufficiency, moderate deficiency, and severe deficiency. No differences regarding demographic and clinical characteristics were found. A survival analysis highlighted that, after 10 days of hospitalization, severe vitamin D deficiency patients had a 50% mortality probability, while those with vitamin D???10 ng/mL had a 5% mortality risk (p?=?0.019).

 

Conclusions

 

High prevalence of hypovitaminosis D was found in COVID-19 patients with acute respiratory failure, treated in a RICU. Patients with severe vitamin D deficiency had a significantly higher mortality risk. Severe vitamin D deficiency may be a marker of poor prognosis in these patients, suggesting that adjunctive treatment might improve disease outcomes.

 

Read More: Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 | SpringerLink

  • Rating:
  • Views:476 views
  • Categories: Health